InvestorsHub Logo
icon url

dadbrotheroftwins

12/10/20 10:24 AM

#287159 RE: raja48185 #287155

Institutional participation will be slow to begin with due to the uncertainity of MOA. What Anavex is doing hasen't been done before, and wall street wants clear direction. Other companies have applications or drugs that tackle known quanties with novel tactics, and if proven successful, are rewarded. Anavex is trying to tackle unknown's (is it Retts, PDD or AD or what) with unproven MOA, so I believe there will be a big wait and see from wall street.
icon url

nidan7500

12/10/20 10:26 AM

#287161 RE: raja48185 #287155

raja

Greedy Wall Street will not wait till that moment. They will be all over the stock like ants on to sugar once the cat is out of the bag (that the data is really good). Look at GLSI for instance.




OK, but do they need to stand back a little and (when proof of AVXL MOA is established/validated) will the BIG GUYS then begin a process of..."Do you know what this really means?" The implications stretch over the horizon, no time to analyze details when the science says...WE GOT .....

The existing models might choke. NICE.